Wen Pin Hsu

PharmaCore Biotech Co., Ltd. engages in the development and production of active pharmaceutical ingredients (APIs), including anti-cancer drugs, peptides, and antibiotics. Its business activities include the development and production of private brand products, the provision of customized Contract Research Organisations and Contract Manufacturing Organisations (CRO/CMO) services, and the provision of Pharmaceutical Inspection Co-operation Scheme (PIC/S) and Good Manufacturing Practice (GMP) relative regulatory and submission services. The company was founded on January 8, 2015 and is headquartered in Tainan, Taiwan.